It’s our pleasure to share with you the Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.
ALLG News is for people, like you, who are interested in medical research and ALLG’s mission to create better treatments and better lives for patients with blood cancers.
As the only non-profit collaborative clinical trials groups in Australia and New Zealand for blood cancers, the ALLG has the capability to run independent doctor-led clinical trials in Australasia and, crucially, to participate in teletrials and international trials; allowing us access to new treatments, with the potential to make a significant impact on patient outcome.
We hope you enjoy reading about ALLG’s world-leading blood cancer research and the impact your support has for patients with blood cancers.
This bumper edition of ALLG News for our 50th year we feature our “Five decades of impact” in clinical trial research for better treatments, better lives. We also feature ground breaking clinical trial HD10 for Advanced-stage Hodgkin lymphoma that provided the “best results we have ever seen in young patients from 18 to 60 years”. You can also read inspiring stories from clinical trial participants, Emma and Bianca, who are back to living their normal lives after participating on ALLG trials for their blood cancer. Read these stories, and more, in this newsletter.
You can read ALLG News Edition 5 here.
Our Laboratory Science research is helping determine which patients benefit from targeted therapy for their blood cancer. You can read about this in our latest newsletter that also includes a heart warming story from Brian who recently celebrated his 70th thanks to being on a lifesaving ALLG clinical trial 15 years ago for his chronic myeloid leukaemia. We also feature some of our latest Life Members of ALLG and a special message from our CEO about ALLG’s five decades of impact, and more, in this newsletter.
You can read ALLG News Edition 4 here.
Our teletrials allow greater access for patients living in rural and regional areas of Australia and New Zealander, to participate on clinical trials; including patients just like Cairns (Australia) resident Vesselin (Vess) Petkov, an anaesthetist who joined an ALLG clinical trial for the treatment of his Mantle Cell Lymphoma. You can read Vess’ story, and more, in this newsletter.
You can read ALLG News Edition 3 here.
Our international clinical trial collaborations bring new treatments to Australians and New Zealanders; including patients just like New Zealander Hemi Frires, a Royal New Zealand Air Force pilot who joined an ALLG clinical trial for the treatment of his Hodgkin Lymphoma. You can read Hemi’s story, and more, in this newsletter.
You can read ALLG News Edition 2 here.
The first ever Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News. ALLG launched our community newsletter in September 2022 during Blood Cancer Awareness Month, a critical time to raise awareness of blood cancers such as leukaemia, lymphoma and myeloma.
You can read ALLG News Edition 1 here.